Dramatic Response to Anti-IL-6 Receptor Therapy in Children With Life-Threatening Myelin Oligodendrocyte Glycoprotein-Associated Disease.

Loren A McLendonClaudia Gambrah-LylesAngela N ViaeneNina A FainbergElizabeth I LandzbergAlexander M TuckerPeter J MadsenJimmy HuhMaya R SilverJohn D ArenaMartha F KienzleBrenda Banwell

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

We propose that IL-6 receptor therapies might also be considered in acute severe life-threatening presentations of MOGAD.

Keyphrases

liver failure
young adults
drug induced
respiratory failure
early onset
stem cells
binding protein
multiple sclerosis
intensive care unit
mesenchymal stem cells
cell therapy